TREGZI
STN: BLA 125868
Proper Name: allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq
Tradename: TREGZI
Manufacturer: Orca Biosystems Inc
Indications:
- For use in matched donor hematopoietic stem cell transplantation with myeloablative preparative regimen, for hematopoietic and immunologic reconstitution and to improve chronic graft-versus-host disease (cGVHD)-free survival, in the treatment of adults with hematological malignancies